Evolving Industry Partnerships and Investments in Cell and Gene Therapies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29656942.
- Also identified by DOI 10.1016/j.stem.2018.03.004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cell and gene therapies hold the promise of providing significant and durable health gains to patients in many disease states and have recently elicited significant investor and partner interest. We cover the current state of industry partnerships and investments, highlight what makes a partnership advantageous, and discuss implications for stem cell therapies.
Medical subject headings
- Cell- and Tissue-Based Therapy
- Genetic Therapy
- Stem Cells